Cardiotoxicity, Vasculitis And PET Biomarker Groups To Be Formed By FDA
Executive Summary
Vasculitis will be the focus of one of the three expert working groups endorsed by FDA's Advisory Committee for Pharmaceutical Science/Nonclinical Studies Subcommittee at its March 9 meeting.